Rodolfo Hurle

Rodolfo Hurle

Auto-generated profile, based on publicly available information

Rodolfo Hurle

Department of Urology, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MMMichela Masetti
Michela Masetti
RCRoberta Carriero
Roberta Carriero
FPFederica Portale
Federica Portale
GMGiulia Marelli
Giulia Marelli
NMNicolò Morina
Nicolò Morina
DMDiletta Di Mitri
Diletta Di Mitri
Tumor-associated macrophages (TAMs) are correlated with the progression of prostatic adenocarcinoma (PCa). The mechanistic basis of this correlation and therapeutic strategies to target TAMs in PCa remain poorly defined. Here, single-cell RNA sequencing was used to profile the transcriptional landscape of TAMs in human PCa, leading to identification of a subset of macrophages characterized by dysregulation in transcriptional pathways associated with lipid metabolism. This subset of TAMs correlates positively with PCa progression and shorter disease-free survival and is characterized by an accumulation of lipids that is dependent on Marco. Mechanistically, cancer cell–derived IL-1β enhances Marco expression on macrophages, and reciprocally, cancer cell migration is promoted by CCL6 released by lipid-loaded TAMs. Moreover, administration of a high-fat diet to tumor-bearing mice raises the abundance of lipid-loaded TAMs. Finally, targeting lipid accumulation by Marco blockade hinders tumor growth and invasiveness and improves the efficacy of chemotherapy in models of PCa, pointing to combinatorial strategies that may influence patient outcomes.

1 May 2006 in Journal of Urology
Verified
Journal Article
Closed access
ABAlberto Briganti
Alberto Briganti
Richard NasproRichard Naspro
Richard Naspro
AGAndrea Gallina
Andrea Gallina
ASAndrea Salonia
Andrea Salonia
IVIvano Vavassori
Ivano Vavassori
FMFrancesco Montorsi
Francesco Montorsi
We compared the impact of HoLEP and TURP on sexual function. Between January 2002 and January 2003, 120 patients with a mean age +/- SD of 65.2 +/- 7.1 years who had benign prostatic hyperplasia were enrolled in this 2-center, prospective, randomized study. A total of 60 patients with a mean age of 65.25 +/- 6.9 years underwent HoLEP (group 1) and 60 with a mean age of 64.18 +/- 7.2 years underwent TURP (group 2). Patients were assessed before surgery, and at 12 and 24-month followup visits. Subjective symptoms were scored by the International Prostate Symptom Score, the International Prostate Symptom Score quality of life question, IIEF, 10 nonvalidated general assessment questions, physical examination, serum prostate specific antigen and transrectal ultrasonography. A total of 32 patients (53.3%) in group 1 and 31 (51.6%) in group 2 reported various degrees of erectile dysfunction before surgery according to the IIEF-EF score. Differences between preoperative and postoperative orgasmic domain scores in each group were significant (p <0.001). A slight but not significant increase in the mean IIEF-EF domain score was reported in each group at postoperative assessments without any difference between the 2 surgical approaches. According to general assessment question analysis the prevalence of subjectively reported postoperative retrograde ejaculation was significantly higher than at baseline assessment in the 2 groups with no differences between the 2 surgical procedures. TURP and HoLEP significantly lowered the IIEF orgasmic function domain with no differences between techniques. This was caused by retrograde ejaculation. Marginal, nonsignificant erectile function improvement was reported after surgery in the 2 groups.

25 April 2015 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
MKMario W. Kramer
Mario W. Kramer
JRJens J. Rassweiler
Jens J. Rassweiler
JKJan Klein
Jan Klein
AMAlexey Martov
Alexey Martov
NBNikolay Baykov
Nikolay Baykov
THThomas R.W. Herrmann
Thomas R.W. Herrmann

1 March 2008 in European Urology
Verified
Journal Article
Closed access
IVIvano Vavassori
Ivano Vavassori
SVSergio Valenti
Sergio Valenti
Richard NasproRichard Naspro
Richard Naspro
AVAlberto Vismara
Alberto Vismara
VDVincenzo Dell'ACqua
Vincenzo Dell'ACqua
RHRodolfo Hurle
Rodolfo Hurle

1 April 2015 in Journal of Urology
Verified
Journal Article
Closed access
Gianluigi TavernaGianluigi Taverna
Gianluigi Taverna
LTLorenzo Tidu
Lorenzo Tidu
Fabio GrizziFabio Grizzi
Fabio Grizzi
VTValter Torri
Valter Torri
AMAlberto Mandressi
Alberto Mandressi
PGPierpaolo Graziotti
Pierpaolo Graziotti
We established diagnostic accuracy in terms of the sensitivity and specificity with which a rigorously trained canine olfactory system could recognize specific volatile organic compounds of prostate cancer in urine samples. Two 3-year-old female German Shepherd Explosion Detection Dogs were trained to identify prostate cancer specific volatile organic compounds in urine samples. They were tested on 362 patients with prostate cancer (range low risk to metastatic) and on 540 healthy controls with no nonneoplastic disease or nonprostatic tumor. This cross-sectional design for diagnostic accuracy was performed at a single Italian teaching hospital and at the Italian Ministry of Defense Military Veterinary Center. For dog 1 sensitivity was 100% (95% CI 99.0-100.0) and specificity was 98.7% (95% CI 97.3-99.5). For dog 2 sensitivity was 98.6% (95% CI 96.8-99.6) and specificity was 97.6% (95% CI 95.9-98.7). When considering only men older than 45 years in the control group, dog 1 achieved 100% sensitivity and 98% specificity (95% CI 96-99.2), and dog 2 achieved 98.6% sensitivity (95% CI 96.8-99.6) and 96.4% specificity (95% CI 93.9-98.1). Analysis of false-positive cases revealed no consistent pattern in participant demographics or tumor characteristics. A trained canine olfactory system can detect prostate cancer specific volatile organic compounds in urine samples with high estimated sensitivity and specificity. Further studies are needed to investigate the potential predictive value of this procedure to identify prostate cancer.

1 August 1999 in Urology
Verified
Journal Article
Closed access
RHRodolfo Hurle
Rodolfo Hurle
ALAndrea Losa
Andrea Losa
AMAlberto Manzetti
Alberto Manzetti
ALAntonio Lembo
Antonio Lembo